X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
43
PharmaCompass offers a list of Doxazosin Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Doxazosin Mesylate manufacturer or Doxazosin Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Doxazosin Mesylate manufacturer or Doxazosin Mesylate supplier.
PharmaCompass also assists you with knowing the Doxazosin Mesylate API Price utilized in the formulation of products. Doxazosin Mesylate API Price is not always fixed or binding as the Doxazosin Mesylate Price is obtained through a variety of data sources. The Doxazosin Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Doxazosin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxazosin, including repackagers and relabelers. The FDA regulates Doxazosin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxazosin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Doxazosin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Doxazosin supplier is an individual or a company that provides Doxazosin active pharmaceutical ingredient (API) or Doxazosin finished formulations upon request. The Doxazosin suppliers may include Doxazosin API manufacturers, exporters, distributors and traders.
click here to find a list of Doxazosin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Doxazosin DMF (Drug Master File) is a document detailing the whole manufacturing process of Doxazosin active pharmaceutical ingredient (API) in detail. Different forms of Doxazosin DMFs exist exist since differing nations have different regulations, such as Doxazosin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Doxazosin DMF submitted to regulatory agencies in the US is known as a USDMF. Doxazosin USDMF includes data on Doxazosin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Doxazosin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Doxazosin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Doxazosin Drug Master File in Japan (Doxazosin JDMF) empowers Doxazosin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Doxazosin JDMF during the approval evaluation for pharmaceutical products. At the time of Doxazosin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Doxazosin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Doxazosin Drug Master File in Korea (Doxazosin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Doxazosin. The MFDS reviews the Doxazosin KDMF as part of the drug registration process and uses the information provided in the Doxazosin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Doxazosin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Doxazosin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Doxazosin suppliers with KDMF on PharmaCompass.
A Doxazosin CEP of the European Pharmacopoeia monograph is often referred to as a Doxazosin Certificate of Suitability (COS). The purpose of a Doxazosin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Doxazosin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Doxazosin to their clients by showing that a Doxazosin CEP has been issued for it. The manufacturer submits a Doxazosin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Doxazosin CEP holder for the record. Additionally, the data presented in the Doxazosin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Doxazosin DMF.
A Doxazosin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Doxazosin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Doxazosin suppliers with CEP (COS) on PharmaCompass.
A Doxazosin written confirmation (Doxazosin WC) is an official document issued by a regulatory agency to a Doxazosin manufacturer, verifying that the manufacturing facility of a Doxazosin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Doxazosin APIs or Doxazosin finished pharmaceutical products to another nation, regulatory agencies frequently require a Doxazosin WC (written confirmation) as part of the regulatory process.
click here to find a list of Doxazosin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Doxazosin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Doxazosin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Doxazosin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Doxazosin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Doxazosin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Doxazosin suppliers with NDC on PharmaCompass.
Doxazosin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Doxazosin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Doxazosin GMP manufacturer or Doxazosin GMP API supplier for your needs.
A Doxazosin CoA (Certificate of Analysis) is a formal document that attests to Doxazosin's compliance with Doxazosin specifications and serves as a tool for batch-level quality control.
Doxazosin CoA mostly includes findings from lab analyses of a specific batch. For each Doxazosin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Doxazosin may be tested according to a variety of international standards, such as European Pharmacopoeia (Doxazosin EP), Doxazosin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Doxazosin USP).
Market Place
